Key result
Oral therapy with ribavirin-2',3',5'-triacetate and (S)-DHPA increased mean survival time in murine rotavirus gastroenteritis, but did not increase the survivor rate.
Population
MA-104 cells infected with simian (SA11) rotavirus and mice with murine rotavirus gastroenteritis
Comparison
RNA virus inhibitors including ribavirin… vs Control (untreated)
Design
Preclinical
Authors
Loading...
Does not improve survivor rate despite longer survival in murine model; hypothesis-generating and requires validation before clinical consideration.
Selected RNA virus inhibitors reduce rotavirus yield in vitro and improve survival time and weight gain in a murine model of rotavirus gastroenteritis.
Smee et al. (1982) studied Simian (SA11) rotavirus infections and murine rotavirus gastroenteritis. RNA virus inhibitors (ribavirin, 3-DG, 3-deazauridine, and (S)-DHPA) vs. control was evaluated on Mean survival time and survivor rate. Oral therapy with ribavirin-2',3',5'-triacetate and (S)-DHPA increased mean survival time in murine rotavirus gastroenteritis, but did not increase the survivor rate.
Synapse has enriched one closely related paper. Consider it for comparative context: